B. Dugovicˇ, L. Fisˇera, H.-U. Reißig
FULL PAPER
7.34, 7.40–7.42 (3 m, 5 H, Ph) ppm. 13C NMR (125 MHz, CDCl3): in water and extracted with hexane, dried with Na2SO4 and concen-
δ = 25.1, 26.5 [2 q, OC(CH3)2O], 54.8 (q, OCH3), 63.2 (t, trated in vacuo. For purification FLC on silica gel (EtOAc/hexane,
NCH2Ph), 65.9 (t, C-5Ј), 66.9 (d, C-3), 77.0 (d, C-4Ј), 102.2 (d, C- 15:85) was employed.
5), 109.3 (s, C-2Ј), 111.5 (t, =CH2), 127.2, 128.2, 128.7, 137.3 (3 d,
Methyl 3-[Benzyl(methyl)amino]-2,3-dideoxy-2-methylene-4,5-O-(1-
methylethylidene)-D-erythro-pentanoate (5a): According to the ge-
s, Ph), 148.8 (s, C-4) ppm. IR (film): ν = 3090 –2830 (=C–H, C–
˜
H), 1675 (C=C), 1605, 1585 [C=C (Ph)] cm–1. MS (EI, 80 eV): m/z
(%) = 305 (7) [M+], 290 (5) [M – CH3]+, 274 (2) [M – OCH3]+,
246 (Ͻ1) [M – C2H3O2]+, 216 (2) [C14H18NO]+, 204 (51) [M –
C5H9O2]+, 101 (8) [C5H9O2]+, 91 (100) [C7H7]+. HRMS: (EI,
80 eV) calcd. for C17H23NO4 305.16272; found 305.16377.
C17H23NO4 (305.4): calcd. C 66.86, H 7.59, N 4.59; found C 66.89,
H 7.68, N 4.59.
neral procedure above, the mixture was treated with MeOTf at 0 °C
for 4.5 h and then with Et3N at 0 to 4 °C for 7 d. After FLC 60 mg
(57%) of 5a (yellow oil) was isolated. Rf = 0.52 (EtOAc/hexane,
15:85). [α]D = +51.1 (c = 1.09, CHCl3). 1H NMR (500 MHz,
CDCl3): δ = 1.35, 1.37 [2 s, 3 H each, OC(CH3)2O], 2.08 (s, 3 H,
NCH3), 3.50, 3.53 (2 d, J = 13.5 Hz, 1 H each, NCH2Ph), 3.79 (s,
3 H, COOCH3), 3.85 (d, J = 9.6 Hz, 1 H, 3-H), 4.01, 4.20 (2 dd, J
= 6.0, 8.4 Hz, 1 H each, 5-H), 4.50 (td, J = 6.0, 9.6 Hz, 1 H, 4-H),
5.78 (br. s, 1 H, =CH2), 6.58 (d, J = 0.8 Hz, 1 H, =CH2), 7.21–7.26
(m, 3 H, Ph), 7.28–7.31 (m, 2 H, Ph) ppm. 13C NMR (125 MHz,
CDCl3): δ = 25.6, 26.8 [2 q, OC(CH3)2O], 37.8 (q, NCH3), 52.0 (q,
COOCH3), 59.2 (t, NCH2Ph), 68.7 (t, C-5), 65.1 (d, C-3), 75.1 (d,
C-4), 109.3 [s, OC(CH3)2O], 126.9, 128.2 (2 d, Ph), 128.3 (t, =CH2),
128.4, 135.5, 139.5 (d, 2 s, Ph, C-2), 168.1 (s, COOCH3) ppm. IR
(3S,5S)-2-Benzyl-3-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-5-meth-
oxy-4-methyleneisoxazolidine (4b): The following characteristic sig-
nals can be unambiguously assigned: 1H NMR (250 MHz, CDCl3):
δ = 1.31, 1.38 [2 s, 3 H each, OC(CH3)2O], 3.45 (s, 3 H, OCH3),
4.36 (d, J = 12.6 Hz, 1 H, NCH2Ph), 5.33–5.34 (m, 1 H, 5-H),
5.54–5.56 (m, 2 H, =CH2) ppm.
(3R,5R)-2-Benzyl-3-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-5-meth-
oxy-4-methylenesoxazolidine (4c): Colourless oil. Rf = 0.40 (EtOAc/
hexane, 15:85). [α]D = +178.4 (c = 1.09, CHCl3). 1H NMR
(500 MHz, CDCl3): δ = 1.32, 1.36 [2 d, J = 0.5 Hz, 3 H each,
OC(CH3)2O], 3.37 (s, 3 H, OCH3), 3.55 (td, J = 2.2, 7.1 Hz, 1 H,
3-H), 3.91 (dd, J = 7.1, 8.3 Hz, 1 H, 5Ј-H), 4.07 (dd, J = 6.4, 8.3 Hz,
1 H, 5Ј-H), 4.08 (d, J = 13.9 Hz, 1 H, NCH2Ph), 4.24 (td, J = 7.1,
6.4 Hz, 1 H, 4Ј-H), 4.27 (d, J = 13.9 Hz, 1 H, NCH2Ph), 5.20 (br.
s, 1 H, 5-H), 5.25, 5.35 (2 dd, J = 1.3, 2.2 Hz, 1 H each, =CH2),
7.24–7.27, 7.30–7.33, 7.40–7.41 (3 m, 5 H, Ph) ppm. 13C NMR
(125 MHz, CDCl3): δ = 25.1, 26.5 [2 q, OC(CH3)2O], 54.9 (q,
OCH3), 62.2 (t, NCH2Ph), 66.5 (t, C-5Ј), 68.5 (d, C-3), 76.0 (d, C-
4Ј), 102.4 (d, C-5), 109.2 (s, C-2Ј), 112.0 (t, =CH2), 127.2, 128.2,
(film): ν = 3105–2795 (=C–H, C–H), 1720 (C=O), 1625 (C=C),
˜
1600, 1585 [C=C (Ph)] cm–1. MS (EI, 80 eV): m/z (%) = 319 (3)
[M+], 304 (6) [M – CH3]+, 288 (Ͻ1) [M – OCH3]+, 218 (64) [M –
C5H9O2]+, 101 (5) [C5H9O2]+, 91 (100) [C7H7]+. C18H25NO4
(319.4): calcd. C 67.69, H 7.89; N 4.39; found C 67.54, H 7.93, N
4.40.
Methyl 3-[Benzyl(methyl)amino]-2,3-dideoxy-2-methylene-4,5-O-(1-
methylethylidene)-D-threo-pentanoate (5b): According to the general
procedure above, the mixture was treated with MeOTf at 0 °C for
3.75 h and then with Et3N at 0 to 4 °C for 3 d. After FLC 79 mg
(75%) of 5b (yellowish oil) was isolated. Rf = 0.43 (EtOAc/hexane,
15:85). [α]D = –33.5 (c = 0.98, CHCl3). 1H NMR (500 MHz,
CDCl3): δ = 1.40, 1.43 [2 s, 3 H each, OC(CH3)2O], 2.24 (s, 3 H,
NCH3), 3.57 (dd, J = 7.2, 8.2 Hz, 1 H, 5-H), 3.60 (d, J = 13.5 Hz,
1 H, NCH2Ph), 3.77 (s, 3 H, COOCH3), 3.79 (dd, J = 1.0, 8.8 Hz,
1 H, 3-H), 3.80 (d, J = 13.5 Hz, 1 H, NCH2Ph), 3.98 (dd, J = 6.4,
8.2 Hz, 1 H, 5-H), 4.62 (ddd, J = 6.4, 7.2, 8.8 Hz, 1 H, 4-H), 5.57
(t, J = 1.0 Hz, 1 H, =CH2), 6.31 (d, J = 1.0 Hz, 1 H, =CH2), 7.20–
7.23, 7.27–7.33 (2 m, 5 H, Ph) ppm. 13C NMR (125 MHz, CDCl3):
δ = 25.5, 26.7 [2 q, OC(CH3)2O], 37.5 (q, NCH3), 52.1 (q, CO-
OCH3), 59.3 (t, NCH2Ph), 65.0 (d, C-3), 67.5 (t, C-5), 75.4 (d, C-
4), 109.7 [s, OC(CH3)2O], 126.2 (t, CH2), 126.7, 128.1, 128.7, 138.0,
129.1, 136.8 (3 d, s, Ph), 148.2 (s, C-4) ppm. IR (film): ν = 3090
˜
–2830 (=C–H, C–H), 1675 (C=C), 1605, 1585 [C=C (Ph)] cm–1.
MS (EI, 80 eV): m/z (%) = 305 (6) [M+], 290 (5) [M – CH3]+, 274
(2) [M – OCH3]+, 247 (1) [M – C3H6O]+, 216 (1) [C14H18NO]+, 204
(54) [M – C5H9O2]+, 101 (6) [C5H9O2]+, 91 (100) [C7H7]+. HRMS:
(EI, 80 eV) calcd. for C17H23NO4 305.16272; found 305.16355.
C17H23NO4 (305.4): calcd. C 66.86, H 7.59, N 4.59; found C 66.77,
H 7.42, N 4.55.
(3R,5S)-2-Benzyl-3-[(4S)-2,2-dimethyl-1,3-dioxolan-4-yl]-5-meth-
1
oxy-4-methyleneisoxazolidine (4d): H NMR (500 MHz, CDCl3): δ
139.8 (3 d, 2 s, Ph, C-2), 167.7 (s, COOCH ) ppm. IR (Film): ν =
˜
= 1.27, 1.32 [2 s, 3 H each, OC(CH3)2O], 3.47 (s, 3 H, OCH3), 3.60
(dd, J = 7.0, 8.6 Hz, 1 H, 5Ј-H), 3.80–3.82 (m, 1 H, 3-H), 3.99 (dd,
J = 6.3, 8.6 Hz, 1 H, 5Ј-H), 4.08 (d, J = 12.7 Hz, 1 H, NCH2Ph),
4.13 (dt, J = 6.3, 7.0 Hz, 1 H, 4Ј-H), 4.40 (d, J = 12.7 Hz, 1 H,
NCH2Ph), 5.30 (dt, J = 1.5, 2.8 Hz, 1 H, 5-H), 5.51, 5.57 (2 t, J =
1.5 Hz, 1 H each, =CH2), 7.25–7.28, 7.31–7.34, 7.38–7.39 (3 m, 5
H, Ph) ppm. 13C NMR (125 MHz, CDCl3): δ = 25.5, 26.3 [2 q,
OC(CH3)2O], 55.9 (q, OCH3), 64.1 (t, NCH2Ph), 65.9 (t, C-5Ј),
68.1 (d, C-3), 76.7 (d, C-4Ј), 106.0 (d, C-5), 109.0 (s, C-2Ј), 114.6
(t, =CH2), 127.4, 128.3, 129.1, 137.0 (3 d, s, Ph), 148.4 (s, C-4)
ppm.
3
3105–2790 (=C–H, C–H), 1720 (C=O), 1650 (C=C), 1600, 1585
[C=C (Ph)] cm–1. MS (EI, 80 eV): m/z (%) = 319 (7) [M+], 304 (19)
[M – CH3]+, 288 (Ͻ1) [M – OCH3]+, 218 (50) [M – C5H9O2]+, 101
(4) [C5H9O2]+, 91 (100) [C7H7]+. C18H25NO4 (319.4): calcd. C
67.69, H 7.89; N 4.39; found C 67.15, H 7.38, N 4.32.
Methyl (2E/2Z)-2-{[Benzyl(methyl)amino]methyl-3-[(4S)-2,2-di-
methyl-1,3-dioxolan-4-yl]}acrylate (6): 1H NMR (500 MHz,
CDCl3): δ = 1.39, 1.45, 1.46 [3 s, 3 H, 1.5 H each, OC(CH3)2O],
2.12, 2.17 (2 s, 1.5 H each, NCH3), 3.05 (dd, J = 1.1, 13.8 Hz, 0.5
H, 1Ј-H), 3.20 (d, J = 12.8 Hz, 0.5 H, 1Ј-H), 3.27 (dd, J = 0.9,
12.8 Hz, 0.5 H, 1Ј-H), 3.33 (td, J = 1.1, 13.8 Hz, 0.5 H, 1Ј-H), 3.43,
3.46, 3.54, 3.55 (4 d, J = 13.0, 13.2 Hz, 0.5 H each, NCH2Ph), 3.61
(dd, J = 6.8, 8.3 Hz, 0.5 H, 5-H), 3.62 (dd, J = 7.3, 8.5 Hz, 0.5 H,
5-H), 3.74, 3.75 (2 s, 1.5 H each, COOCH3), 4.18 (dd, J = 6.5,
8.2 Hz, 0.5 H, 5-H), 4.31 (dd, J = 6.8, 8.3 Hz, 0.5 H, 5-H), 4.93
(ddd, J = 6.5, 7.3, 8.5 Hz, 0.5 H, 4-H), 5.17 (q, J = 6.8 Hz, 0.5 H,
4-H), 6.21 (td, J = 1.1, 6.8 Hz, 0.5 H, 3-H), 6.81 (dd, J = 0.9,
8.5 Hz, 0.5 H, 3-H), 7.28 (m, 5 H, Ph) ppm. 13C NMR (125 MHz,
CDCl3): δ = 25.5, 25.7, 26.6 [3 q, OC(CH3)2O], 41.7, 42.0 (2 q,
NCH3), 51.7, 52.0 (2 q, COOCH3), 52.4, 59.5 (2 t, C-1Ј), 61.9, 62.5
N-Methylation and Redox Cleavage of Isoxazolidines: The corre-
sponding isoxazolidine 4 (as diastereomeric mixture of 3,5-cis/3,5-
trans, 0.100 g, 0.33 mmol) was dissolved in acetonitrile (2 mL). The
solution was treated with methyl triflate (0.041 mL, 0.36 mmol,
1.1 equiv.) at 0 °C and the resulting mixture was stirred at 0 °C for
the time given in the individual experiments until the starting mate-
rial was consumed. The mixture was then treated with triethyl-
amine (0.137 mL, 0.98 mmol, 3 equiv.) and stirred for the given
time until the isoxazolidinium salt disappeared (tlc control). After
all volatile components had been removed the residue was dissolved
282
www.eurjoc.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2008, 277–284